Edwin Jabbari

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism.

Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism.

Journal: BMJ open
Published: July 29, 2026

Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson's Progression Marker Initiative.

Consistency of Serial CSF alpha-Synuclein Seed Amplification Assay Results in the Parkinson's Progression Marker Initiative.

Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Journal: Brain : a journal of neurology
Published: December 15, 2025

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 24, 2025

Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes.

Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes.

Journal: Brain : a journal of neurology
Published: August 02, 2025

Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes.

Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes.

Journal: Brain : a journal of neurology
Published: August 02, 2025

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Journal: The Lancet. Neurology
Published: December 10, 2024

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 06, 2024

Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism.

Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism.

Journal: Journal of neurology
Published: November 03, 2024

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

Journal: Lancet (London, England)
Published: October 07, 2024

Academic neurology in the UK: a plea to turn away from the precipice.

Academic neurology in the UK: a plea to turn away from the precipice.

Journal: Brain : a journal of neurology
Published: April 12, 2024

NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.

NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 28, 2024
Showing 1-12 of 38

Last Updated: 09/26/2026